Your session is about to expire
← Back to Search
VRT Care for Vertigo (AVERT Trial)
AVERT Trial Summary
This trial will compare the accuracy of diagnoses and initial management decisions for emergency department patients with a chief symptom of vertigo or dizziness when using video-oculography (VOG) versus standard care.
- Vertigo
- Dizziness
AVERT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowAVERT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.AVERT Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the prevalence of this experiment in US medical institutions?
"This trial is inviting participants to enrol at Mt. Sinai Medical Center in New york, Massachusetts General Hospital in Boston, and University of Michigan in Ann Arbor. Additionally, other five sites are also participating."
Are there any openings remaining in this research initiative?
"At present, clinicaltrials.gov states that this study is not presently recruiting patients, despite having been initially posted on December 4th 2017 and most recently edited on August 11th 2022. Nevertheless, there are still 219 other trials actively looking for participants to participate in their research."
What aims does this research endeavor hope to accomplish?
"This medical trial's primary outcome is to measure total diagnostic utilization costs over a 6 month period from the conclusion of treatment. Secondary outcomes include assessing algorithm-only VRT diagnosis accuracy compared to standard of care, preventing six-category diagnoses errors in comparison to SOC, and gauging VRT versus MRI stroke/no stroke diagnosis accuracy (VRT arm only)."
Share this study with friends
Copy Link
Messenger